How medigini works

medigini answers clinical questions from registered medical practitioners in India with short answers that cite their sources. This page explains where the answers come from, the rules they follow and their limits. medigini is a work in progress (beta), so details will change.

From question to answer

1. Understanding the question. An AI model turns your question into searches: a PubMed search, search words for Indian journals, and a suggested search for the current Indian guideline.
2. Finding evidence. medigini searches PubMed three ways at once: for the strongest evidence (guidelines, systematic reviews, meta-analyses and trials), for recent studies of any kind, and for Indian evidence (Indian journals and studies from India). At the same time it searches about 200 Indian medical journals, most of which PubMed doesn't index, and keeps only articles clearly about your question.
3. Checking Indian guidelines. Before writing, the AI is told to search a fixed list of guideline websites, starting with Indian ones: ICMR, the Ministry of Health and Family Welfare and its national programmes (such as NTEP, NCVBDC and NACO), the National Health Mission, CDSCO and Indian professional societies, then the WHO and a few international guideline bodies.
4. Writing the answer. The answer starts with a direct answer, then short headed sections. Factual sentences carry numbered citations, and the references below the answer list each source with its authors, journal and year, or its issuing body. Indian sources are listed first.
5. Follow-up questions. Three suggested questions follow each answer, and you can ask your own. medigini uses your last three questions and answers as context. You can edit any question, even while its answer is still being written; the answers after it are then removed. You can also stop an answer while it is being written.

Search gives a short answer, usually in under a minute. Deep Dive reads more sources and returns a longer, structured review; it opens once sign-in is switched on.

Sources

• PubMed (US National Library of Medicine): abstracts of published studies, mostly from the last 15 years, including the Indian journals indexed there.
• Indian journals, through the Directory of Open Access Journals (DOAJ): about 200 Indian medical journals. The list is checked by hand so that foreign journals printed in India are left out, and it is reviewed regularly. These articles are labelled "Indian journal" in the references.
• Guideline websites: the public pages and documents of Indian government bodies and national programmes, Indian professional societies, the WHO, NICE, KDIGO, ESC, GINA, GOLD and the American Diabetes Association.

medigini reads abstracts and public pages, not paid full-text articles. It has no licence, partnership or endorsement from any publisher, society or government body: a website being on the list only means that its public pages are searched.

Editorial and safety rules

Every answer is written under the same rules:

• For a disease with a national programme (such as tuberculosis, HIV, malaria, dengue, leprosy, viral hepatitis, immunisation, and maternal and newborn care), the programme guideline comes first, as the national standard of care.
• Otherwise guidance is ranked: ICMR Standard Treatment Workflows and ICMR, NCDC or DGHS guidelines; then current Indian professional society guidelines; then the WHO; then other international guidelines; then systematic reviews and trials.
• The newest edition wins. Each guideline is named with its issuing body and year. An Indian guideline more than five years old, or one that newer evidence disagrees with, is pointed out.
• Medicines are named by generic name only, with no brands, companies or prices. Fixed-dose combinations that CDSCO has banned or restricted are never recommended, and use outside an approved Indian indication is called off-label.
• For antibiotics, Indian resistance data and Indian antimicrobial guidelines come first.
• PubMed sources with authors from drug companies are labelled "Industry authors", and the AI is told to say so and not to base the direct answer on them. Small studies, case reports and old or indirect evidence are described as such.
• If the sources don't answer the question, the answer says so.
• Answers cover modern medicine unless you ask about an AYUSH system.

Limits

• AI can misread or overstate a study, miss a new drug or an unusual situation, and cite a source that doesn't say exactly what the summary suggests. Check the sources before you act.
• medigini doesn't replace clinical judgement, current prescribing information or the full guideline.
• There is no published accuracy score, because none has been measured yet.
• Users' medical registration is not verified yet.

If you find an error, use Report a problem under the answer, or write to hello@medigini.in.

Patient data

Don't enter patient names, phone numbers, or ID or record numbers. If you attach or scan a report, cover the patient's name first: medigini reads the values from the report and doesn't keep the file. The Privacy policy has the details.

Reporting adverse drug reactions

Report suspected adverse drug reactions to the Pharmacovigilance Programme of India (PvPI).

Last updated: 17 October 2026